Best of JAMA Network 2024
Revisit the most viewed videos at JAMA and the JAMA Network in 2024.
Related Articles
CSF Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Spectrum
This cohort study analyzes changes in cerebrospinal fluid (CSF) biomarkers and cognition among individuals in different stages of the Alzheimer disease clinical spectrum.
Systemic Strategies to Prevent Nonbeneficial Treatments Near the End of Life
This qualitative study evaluates what factors clinicians and caregivers of people living with dementia in Great Britain perceive to shape treatment intensity toward the end…
Incorporating Ethics in Infectious Diseases Guidelines
This scoping review evaluates whether clinical practice guidelines in infectious disease include ethical considerations.
Improving Patients’ Treatment Expectations
This JAMA Insights offers evidence-based communication strategies for addressing patient treatment expectations, which can improve outcomes and reduce adverse effects.
FDA Approves First Twice-Yearly PrEP for Long-Acting HIV Prevention
The US Food and Drug Administration (FDA) recently approved lenacapavir, marketed as Yeztugo, as the first twice-yearly preexposure prophylaxis (PrEP) that reduces HIV risk.
Endocrine Society (ENDO)
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
Endocrine Society (ENDO)
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
Education, Lifestyle, and Treatment Choices and Multiple Sclerosis Progression
This cohort study evaluates the association between educational level and disability progression in patients with multiple sclerosis.
Use of Tobacco and Cannabis Following State-Level Cannabis Legalization
This cohort study assesses whether there were changes in the use of cannabis, cigarettes, and electronic nicotine delivery systems among US adults during 5 years…
Endocrine Society (ENDO)
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
